Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Nainesh Parikh

Vascular & Interventional Radiology Tampa, FL Medical Doctor

NPI 1205151966 CMS profile 1320408

12902 Usf Magnolia Dr, Mail Stop Wcb-Rad MD/Opi, Tampa, FL 33612

Open in the dashboard

General payments

$31,291

126 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Nainesh Parikh of Tampa, FL is reported in the CMS Open Payments database as having received $31,291 across 126 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 88th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $8,539 30
2024 General $1,569 15
2023 General $6,249 29
2022 General $9,066 20
2021 General $4,115 14
2020 General $1,044 11
2019 General $710 7

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Nainesh Parikh
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Nainesh Parikh were reported at $8,539. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Nainesh Parikh Vascular & Interventional Radiology median Middle half National median
2019 $710 $422 $125–$1,555 $163
2020 $1,044 $200 $68–$652 $114
2021 $4,115 $280 $99–$866 $132
2022 $9,066 $433 $137–$1,497 $149
2023 $6,249 $506 $152–$2,019 $160
2024 $1,569 $556 $175–$1,930 $164
2025 $8,539 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Canon Medical Systems USA, Inc. $15,963 13 payments
  2. Penumbra, Inc. $7,844 25 payments
  3. Sirtex Medical Inc $1,202 5 payments
  4. Inari Medical, Inc. $1,201 14 payments
  5. Boston Scientific Corporation $1,089 18 payments
  6. Balt USA, LLC $628 6 payments
  7. ABK Biomedical USA, Inc. $610 4 payments
  8. Medtronic, Inc. $568 10 payments
  9. Siemens Medical Solutions USA, Inc. $385 5 payments
  10. AngioDynamics, Inc. $377 5 payments
  11. Other $1,424 21 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $14,000 6 payments
  2. Food and Beverage $8,541 105 payments
  3. Travel and Lodging $4,951 14 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $3,800 1 payment
Products named General payments · program years 2019–2025
  1. TOSHIBA SCANNER $8,121 3 payments
  2. Indigo System $6,010 17 payments
  3. INTERVENTIONAL ANGIOGRAPHY SYSTEM $3,162 3 payments
  4. Angio Workstation Software $3,121 2 payments
  5. CT (Computed Tomography) $2,500 1 payment
  6. RUBY Coil $1,699 7 payments
  7. FLOWTRIEVER CATHETER, S $1,370 16 payments
  8. Rotating Anode X-ray Tube Assembly $1,348 2 payments
  9. SIR-Spheres Microspheres $1,202 5 payments
  10. CT THROMBECTOMY SYSTEM KIT $1,032 12 payments
  11. Other $4,584 64 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

171

Median for Interventional Radiology: 38

Drug cost

$841

Median for Interventional Radiology: $333

Branded share of claims

36.3%

Median for Interventional Radiology: 53%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxybutynin Chloride Generic 51 $489
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim Brand 62 $205
Ibuprofen Generic 58 $146

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 554 Part D prescribers listed as Interventional Radiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 69 billing codes

Paid by Medicare

$56,531

Medicare's payments for the services billed

Medicare patients

143

Average age 73

Services billed

600

39 women, 104 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Cancer 73%
Arthritis 43%
Ischemic heart disease 36%
Chronic kidney disease 30%
Diabetes 28%
Atrial fibrillation 24%
COPD 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

126 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record